RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream
Generic name
SALICYLIC ACID 3%
Manufacturer
RoyceDerm LLC
Product type
HUMAN OTC DRUG
SPL set ID
496e178b-e29b-071e-e063-6394a90aa018
SPL ID
58f4e362-f8a4-4be8-e063-6394a90a84cc
Version
2
Effective date
2026-08-13
Source export date
2026-11-13
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/2aa9706206c534e56285cf80077b2cca2320f0a236e2aa30e80d064749f7c888/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:03:08
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Ask a doctor before use you havea condition that covers a large area of the body. When usingthis product avoid contact with eyes. If contact occurs, rinse theeyes thoroughly with water. Stop and ask a doctor if conditionworsens or does not improve after regular use of this productas directed. If swallowed, getmedical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.